Paul England writes on COVID-19 drug supply and patent system for 'Manufacturing Chemist'


The patent system has come under pressure both politically and, more recently, as pharma companies scale-up their operations to make large amounts of drugs available to treat COVID-19.

Paul England of Taylor Wessing outlines what leverage governments have in international negotiations for supplies, particularly when drugs are covered by patents that give them or their chosen licensees the exclusive right to manufacture.

To read more information, click here.

Taylor Wessing is a full-service international law firm, working with clients in the world’s most dynamic industries. We take a single-minded approach to advising our clients, helping them succeed by thinking innovatively about their business issues. We support clients wherever they want to do business. The firm has a sector focus with experts in technology, media and communications, life sciences and private

Taylor Wessing